Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-18

Clinical Trial Update: Effects of the Sherborne Developmental Movement Program on Motor Performance in Children With Autism Spectrum Disorders [NA]

View source ↗

Summary

This clinical trial update notes the completion of a study evaluating the Sherborne Developmental Movement Program's effects on motor performance in children wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Elif Dilan ATILGAN | Conditions: Autism Spectrum Disorder | NA | Status: COMPLETED